A Study to Evaluate the Safety and Effectiveness of the 217z Laser Zyoptix for Lasik - Full Text View

Home Search Study Topics Glossary

A Study to Evaluate the Safety and Effectiveness of the 217z Laser Zyoptix for Lasik

This study has been suspended.

Sponsored by:	Bausch & Lomb, Inc.
Information provided by:	Bausch & Lomb, Inc.
ClinicalTrials.gov Identifier:	NCT00347997

Purpose

A Study to demonstrate the safety and efficacy of wavefront laser refractive surgery treatments for myopia and astigmatism.

Condition	Intervention
Myopia Astigmatism	Device: 217z Laser

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00347997

Sponsors and Collaborators

Bausch & Lomb, Inc.

Investigators

Study Director:

Mohinder Merchea, OD, PhD

Bausch & Lomb, Inc.

More Information

Study ID Numbers:	385
Study First Received:	June 30, 2006
Last Updated:	May 2, 2007
ClinicalTrials.gov Identifier:	NCT00347997
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Eye Diseases
Myopia
Refractive Errors
Astigmatism

ClinicalTrials.gov processed this record on January 14, 2009